ABIGAIL LANGKABEL: Open Payments
NPI 1760869002 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,793 in 80 payments from 23 companies in 2025. Trend: 2023 $469 · 2024 $1,839 · 2025 $2,793
Food & beverage: $1,838Speaker / faculty: $800Consulting: $120Education: $35
| Company | Payments | Amount |
|---|---|---|
| AVYXA PHARMA, LLC | 1 | $800 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $270 |
| ACCORD HEALTHCARE, INC. | 10 | $246 |
| Sumitomo Pharma America, Inc. | 9 | $244 |
| UROGEN PHARMA, INC. | 6 | $129 |
| Endo USA, Inc. | 6 | $125 |
| Janssen Global Services, LLC | 1 | $120 |
| PFIZER INC. | 6 | $119 |
| Ferring Pharmaceuticals Inc. | 3 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
Products named: Nubeqa, Camcevi, ORGOVYX, XTANDI, ERLEADA, AVEED, ADSTILADRIN, JELMYTO.
Industry payments across IN — which companies pay providers there.
